NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
9.45
+0.11 (1.18%)
Oct 14, 2025, 3:43 PM EDT - Market open
NeoGenomics Employees
NeoGenomics had 2,200 employees as of December 31, 2024. The number of employees increased by 100 or 4.76% compared to the previous year.
Employees
2,200
Change (1Y)
100
Growth (1Y)
4.76%
Revenue / Employee
$313,268
Profits / Employee
-$47,290
Market Cap
1.22B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2,200 | 100 | 4.76% |
| Dec 31, 2023 | 2,100 | 0 | - |
| Dec 31, 2022 | 2,100 | 100 | 5.00% |
| Dec 31, 2021 | 2,000 | 300 | 17.65% |
| Dec 31, 2020 | 1,700 | 0 | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NEO News
- 8 hours ago - NeoGenomics to Highlight RaDaR ST MRD Assay at ESMO Congress 2025 - Business Wire
- 7 days ago - NeoGenomics to Report Third Quarter 2025 Financial Results on October 28, 2025 - Business Wire
- 27 days ago - NeoGenomics Stock In A Range-Bound Matrix, Weakness Likely Until 2026 - Benzinga
- 6 weeks ago - NeoGenomics Gains 'Unexpected' Win As Court Rejects Natera Claims - Benzinga
- 6 weeks ago - Court Rules for NeoGenomics in Patent Infringement Lawsuit Against Natera - Business Wire
- 2 months ago - Neo Performance Materials Inc. (NOPMF) Q2 2025 Earnings Conference Call Transcript - Seeking Alpha
- 2 months ago - NeoGenomics Launches PanTracer LBx, Expanding Access to Comprehensive Genomic Profiling with Liquid Biopsy - Business Wire
- 2 months ago - NeoGenomics, Inc. (NEO) Q2 2025 Earnings Call Transcript - Seeking Alpha